Showing results (31-40 of 107) with videos related to
Sort By:
Pageof 11
The Journal of Allergy and Clinical Immunology. in Practice|January 21, 2024
What a Clinician Needs to Know About Genome Editing: Status and Opportunities for Inborn Errors of ImmunityAnne C A Mudde, Caroline Y Kuo, Donald B Kohn, et al.British Journal of Clinical Pharmacology|December 28, 2025
Pharmacokinetic modelling of intravenous immunoglobulin in children with primary immunodeficiencies and secondary antibody deficienciesIek Leng Cheng, Zhong Hui Huang, Austen Worth, et al.Journal of Clinical Immunology|December 21, 2019
Chest Radiographs for Distinguishing ADA-SCID from Other Forms of SCIDMartijn V Verhagen, Valentina Trevisan, John Adu, et al.The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2023
Updated Management Guidelines for Adenosine Deaminase DeficiencyEyal Grunebaum, Claire Booth, Geoffrey D E Cuvelier, et al.Journal of Clinical Immunology|May 17, 2022
Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and ChildhoodJames W Day, Reem Elfeky, Bethany Nicholson, et al.Blood|December 11, 2012
SAP gene transfer restores cellular and humoral immune function in a murine model of X-linked lymphoproliferative diseaseChristine Rivat, Claire Booth, Maria Alonso-Ferrero, et al.The Journal of Allergy and Clinical Immunology|April 30, 2018
Transfer of gene-corrected T cells corrects humoral and cytotoxic defects in patients with X-linked lymphoproliferative diseaseNeelam Panchal, Ben Houghton, Begona Diez, et al.Nature Immunology|August 23, 2022
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulationAlan Kennedy, Erin Waters, Behzad Rowshanravan, et al.Tropical Animal Health and Production|May 31, 2024
Ultrasonographic, endoscopic and radiographic examinations of the dromedary mammary glands and teatsMüller Annika, Ulrich Wernery, Jörg Kinne, et al.Leukemia Research Reports|February 24, 2022
Gilteritinib monotherapy as a transplant bridging option for high risk <i>FLT3</i>-mutated AML with t(6;9)(p23;q34.1);DEK-NUP214 in morphological but not cytogenetic or molecular remission following standard induction chemotherapyJames W Day, Thomas A Fox, Rajeev Gupta, et al.Pageof 11